Patents by Inventor Anne Donnet
Anne Donnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9226521Abstract: A nutritional composition is proposed comprising a probiotic and milk fat globule membrane (MFGM) wherein the MFGM and the probiotics mutually potentiate their respective effects and promote complementary beneficial protective mechanisms that reflect physiological synergy. The nutritional composition can be an infant formula, infant cereals, baby food or health care nutritional product. The synergistic effect can include promoting immune maturation and/or immune education and/or reducing inflammation and/or treating or preventing disease or infections.Type: GrantFiled: December 7, 2010Date of Patent: January 5, 2016Assignee: Nestec S.A.Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Lionel Jean Rene Bovetto, Isabelle Bureau-Franz, Anne Donnet-Hughes, Eduardo Schiffrin, Laurent Favre
-
Publication number: 20140056927Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or opthalmological applications, a food or petfood composition for modulating bacterial colonisaion, immune responses and decreasing the inflammatory processes, associated with bacterially mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and rectal cavity. The invention also relates to lipoteichoic acid selected thereof.Type: ApplicationFiled: August 15, 2013Publication date: February 27, 2014Applicant: NESTEC S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Patent number: 8377430Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.Type: GrantFiled: April 10, 2006Date of Patent: February 19, 2013Assignee: Nestec S.A.Inventors: Anne Donnet-Hughes, Eduardo Schiffrin, Ferdinand Haschke, Marie-Claire Fichot, Karl-Josef Huber-Haag
-
Publication number: 20120321600Abstract: A nutritional composition is proposed comprising a probiotic and milk fat globule membrane (MFGM) wherein the MFGM and the probiotics mutually potentiate their respective effects and promote complementary beneficial protective mechanisms that reflect physiological synergy. The nutritional composition can be an infant formula, infant cereals, baby food or health care nutritional product. The synergistic effect can include promoting immune maturation and/or immune education and/or reducing inflammation and/or treating or preventing disease or infections.Type: ApplicationFiled: December 7, 2010Publication date: December 20, 2012Applicant: NESTEC S.A.Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Lionel Jean Rene Bovetto, Isabelle Bureau-Franz, Anne Donnet-Hughes, Eduardo Schiffrin, Laurent Favre
-
Patent number: 8329190Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonization, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: GrantFiled: October 7, 2008Date of Patent: December 11, 2012Assignees: Societe des Produits Nestle S.A., Nestec S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Patent number: 7749960Abstract: The present invention pertains to osteoprotegerin obtainable from milk sources, in particular human and bovine milk. The present invention also relates to the use thereof for preparing an ingestible preparation and/or a pharmaceutical composition, in particular to the use of such a preparation/composition for preventing or treating disorders associated with bone metabolism and immune function.Type: GrantFiled: October 2, 2003Date of Patent: July 6, 2010Assignee: Nestec S.A.Inventors: Karine Vidal, Peter Van Den Broek, Elizabeth Offord Cavin, Anne Donnet-Hughes
-
Publication number: 20090304655Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.Type: ApplicationFiled: April 10, 2006Publication date: December 10, 2009Applicant: NESTEC S.A.Inventors: Anne Donnet-Hughes, Eduardo Schiffrin, Ferdinand Haschke, Marie-Claire Fichot, Karl-Josef Huber-Haag
-
Publication number: 20090142375Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonisation, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: ApplicationFiled: October 7, 2008Publication date: June 4, 2009Applicants: SOCIETE DES PRODUITS NESTLE S.A., NESTEC S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Patent number: 7524815Abstract: The present invention pertains to osteoprotegerin obtainable from milk sources, in particular human and bovine milk. The present invention also relates to the use thereof for preparing an ingestible preparation and/or a pharmaceutical composition, in particular to the use of such a preparation/composition for preventing or treating disorders associated with bone metabolism and immune function.Type: GrantFiled: June 2, 2005Date of Patent: April 28, 2009Assignee: Nestec S.A.Inventors: Karine Vidal, Peter Van Den Broek, Elizabeth Offord Cavin, Anne Donnet-Hughes
-
Patent number: 7468193Abstract: The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-? and free glutamine.Type: GrantFiled: October 14, 2004Date of Patent: December 23, 2008Assignee: Nestec S.A.Inventors: Eduardo Schiffrin, Denis Breuillé, Stéphanie Blum-Sperisen, Anne Donnet-Hughes, Magali Faure, Claudia Roessle, Marco Enrico Turini
-
Publication number: 20070042021Abstract: The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-? and free glutamine.Type: ApplicationFiled: October 14, 2004Publication date: February 22, 2007Inventors: Eduardo Schiffrin, Denis Breuille, Stephanie Blum-Sperisen, Anne Donnet-Hughes, Magali Faure, Claudia Roessle, Marco Turini
-
Publication number: 20050288219Abstract: The present invention pertains to osteoprotegerin obtainable from milk sources, in particular human and bovine milk. The present invention also relates to the use thereof for preparing an ingestible preparation and/or a pharmaceutical composition, in particular to the use of such a preparation/composition for preventing or treating disorders associated with bone metabolism and immune function.Type: ApplicationFiled: June 2, 2005Publication date: December 29, 2005Inventors: Karine Vidal, Peter Van Den Broek, Elizabeth Offord Cavin, Anne Donnet-Hughes
-
Publication number: 20040147010Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood compostiion for modulating bacterial colonisation, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: ApplicationFiled: November 18, 2003Publication date: July 29, 2004Inventors: Karine Vidal, Anne Donnet-Hugues, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Publication number: 20040137074Abstract: The present invention pertains to osteoprotegerin obtainable from milk sources, in particular human and bovine milk. The present invention also relates to the use thereof for preparing an ingestible preparation and/or a pharmaceutical composition, in particular to the use of such a preparation/composition for preventing or treating disorders associated with bone metabolism and immune function.Type: ApplicationFiled: October 2, 2003Publication date: July 15, 2004Inventors: Karine Vidal, Peter Van Den Broek, Elizabeth Offord Cavin, Anne Donnet-Hughes
-
Patent number: 5603930Abstract: Lactobacillus johnsonii strain CNCM I-1225 adheres to Caco-2 cells and inhibits adhesion thereto by enterovirulent and enteroinvasive pathogens.Type: GrantFiled: May 31, 1995Date of Patent: February 18, 1997Assignee: Nestec S.A.Inventors: Dominique Brassart, Anne Donnet, Harriet Link, Olivier Mignot, Jean-Richard Neeser, Florence Rochat, Eduardo Schiffrin, Alain Servin
-
Patent number: 5494664Abstract: Bifidobacterium breve CNCM I-1226, Bifidobacterium infantis CNCM I-227 and Bifidobacterium longum CNCM I-1228 adhere to and competitively exclude pathogenic bacteria from Caco-2 cells. The strains may be incorporated into yogurts, acidified milks and other food compositions.Type: GrantFiled: April 28, 1995Date of Patent: February 27, 1996Assignee: Nestec S.A.Inventors: Dominique Brassart, Anne Donnet, Harriet Link, Olivier Mignot, Jean-Richard Neeser, Florence Rochat, Eduardo Schiffrin, Alain Servin
-
Patent number: 5461033Abstract: The expression of Class II antigen expression by intestinal epithelial cells is modulated by administering to a mammal in need thereof an effective amount of TGF-.beta.2.Type: GrantFiled: February 21, 1995Date of Patent: October 24, 1995Assignee: Nestec S.A.Inventors: Anne Donnet, Anthony C. Huggett, Eduardo Schiffrin